Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9091 |
High Similarity |
NPD920 |
Approved |
0.9 |
High Similarity |
NPD1243 |
Approved |
0.8921 |
High Similarity |
NPD2796 |
Approved |
0.8819 |
High Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8811 |
High Similarity |
NPD643 |
Clinical (unspecified phase) |
0.869 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8658 |
High Similarity |
NPD6801 |
Discontinued |
0.8621 |
High Similarity |
NPD6799 |
Approved |
0.86 |
High Similarity |
NPD7819 |
Suspended |
0.86 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8591 |
High Similarity |
NPD7411 |
Suspended |
0.8451 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8451 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8435 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8403 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8377 |
Intermediate Similarity |
NPD919 |
Approved |
0.8322 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8298 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8276 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8273 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8219 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8207 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8163 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8158 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8156 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8117 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8028 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7975 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7971 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7947 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7929 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7929 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7925 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7898 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7881 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7872 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3226 |
Approved |
0.784 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7821 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7801 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7793 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3268 |
Approved |
0.777 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7764 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7733 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7676 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7673 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7626 |
Intermediate Similarity |
NPD17 |
Approved |
0.7619 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7619 |
Intermediate Similarity |
NPD1933 |
Approved |
0.76 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7576 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD2403 |
Approved |
0.756 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD411 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5890 |
Approved |
0.75 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7465 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7456 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7438 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7391 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7383 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7381 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7357 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD943 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7284 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7247 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD7003 |
Approved |
0.72 |
Intermediate Similarity |
NPD3142 |
Approved |
0.72 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7193 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7183 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7176 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7164 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD6279 |
Approved |
0.716 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2186 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7102 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1164 |
Approved |
0.707 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7014 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1283 |
Approved |
0.6994 |
Remote Similarity |
NPD6386 |
Approved |
0.6994 |
Remote Similarity |
NPD6385 |
Approved |
0.6993 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6989 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6987 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6982
|
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |